Opinion
Where Is the Line?
Connecticut’s cannabis industry openly honors the lawmakers and regulators who shape its market. Maybe the problem isn’t what’s hidden. Maybe it’s what we’ve decided is normal.
Front Page › Money & Influence
Money & Influence
Campaign money, lobbying, political relationships, federal probes and conflicts of interest.
Analysis
Equity Grants Need Public Trust. So Why Is Doug McCrory Hosting the Forum?
As Connecticut prepares to distribute millions of dollars in cannabis tax revenue through the Social Equity Council’s Reimagine & Revitalize (R2) Community Reinvestment Program, an uncomfortable question is emerging:
FBI-Linked Blue Hills Investigation Raises Questions Near the Social Equity System
A federal investigation into the collapse of a Hartford nonprofit is raising new oversight questions that now sit uncomfortably close to Connecticut’s cannabis social equity system.
House Majority Leader Jason Rojas’ PAC Took Cannabis-Linked Money Tied to Crisp Network
Three dispensary entities connected to the same business structure made coordinated payments into leadership PAC.
Opinion
Corporate Cannabis Blames the 'Illicit Market.' Connecticut Built It.
First and foremost, never forget that CT Cannabis Corporations are lobbying against your personal freedom and rights, and actively advocating for enforcement against the legacy market, all while blaming the little guys, the basement growers, for their corporations failures.
Investigation
Connecticut Taxpayers Fund a National Regulator Network. DCP's Commissioner Sits on Its Board
How Connecticut quietly pays into a secretive national association that helps write cannabis policy behind closed doors — while one of our own regulators helps lead it.
Opinion
Why the Social Equity Council's 'Partner Awards' Expose a Conflict of Interest
When the Social Equity Council (SEC) announced its 2025 “Partner Award” honorees this week, the post looked harmless — smiling photos, hashtags about leadership, polished talking points about “equity in action.”
The Cicero Connection: Cannabis, Power and the Expanding Federal Probe
A NEW NAME EMERGES IN CONNECTICUT’S CANNABIS EQUITY LANDSCAPE — AND IN A FEDERAL PROBE
InvestigationAnalysis
Corrected: Who Really Controls Connecticut Cannabis
Connecticut’s cannabis market was supposed to open the door for hundreds of small, locally owned businesses.
Investigation
The Hidden Empire: How the Zachs and Patels Captured the 'Equity' Cannabis Market
All data sourced from the Connecticut eLicense Lookup – verifiable public record (https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx)
State Records Confirm Silver Point Subsidiary Now Holds Theraplant's License
Public records now confirm that DXR Finance 3, LLC, a corporate affiliate of Silver Point Capital, currently holds Connecticut Medical Marijuana Producer License MMPR.0000004 at 856 Echo Lake Road in Watertown — the same facility historically operated by Theraplant LLC.
Investigation
ARPA Funds Meant for a Downtown Market Appear Diverted Toward Dispensary Linked to Former Regulator
A formal fraud-risk review request has been submitted to the Connecticut Auditors of Public Accounts, calling for an investigation into the City of Middletown’s use of $2.5 million in ARPA funds earmarked for Main Street redevelopment.